172 related articles for article (PubMed ID: 24931218)
1. New advances in treating thrombotic diseases: GPVI as a platelet drug target.
Jiang P; Jandrot-Perrus M
Drug Discov Today; 2014 Sep; 19(9):1471-5. PubMed ID: 24931218
[TBL] [Abstract][Full Text] [Related]
2. The future of glycoprotein VI as an antithrombotic target.
Zahid M; Mangin P; Loyau S; Hechler B; Billiald P; Gachet C; Jandrot-Perrus M
J Thromb Haemost; 2012 Dec; 10(12):2418-27. PubMed ID: 23020554
[TBL] [Abstract][Full Text] [Related]
3. [Advances of Studies on Platelet GPVI as Antithrombotic Target -Review].
Li P; Qiao JL; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):264-269. PubMed ID: 28245414
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein VI - novel target in antiplatelet medication.
Borst O; Gawaz M
Pharmacol Ther; 2021 Jan; 217():107630. PubMed ID: 32681846
[TBL] [Abstract][Full Text] [Related]
5. Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway.
Stegner D; Haining EJ; Nieswandt B
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1615-20. PubMed ID: 24925975
[TBL] [Abstract][Full Text] [Related]
6. Platelet GPVI: a target for antithrombotic therapy?!
Dütting S; Bender M; Nieswandt B
Trends Pharmacol Sci; 2012 Nov; 33(11):583-90. PubMed ID: 22901552
[TBL] [Abstract][Full Text] [Related]
7. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
[TBL] [Abstract][Full Text] [Related]
8. Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.
Kraft P; De Meyer SF; Kleinschnitz C
J Cereb Blood Flow Metab; 2012 Oct; 32(10):1831-40. PubMed ID: 22805877
[TBL] [Abstract][Full Text] [Related]
9. Platelet Inhibitors.
Shifrin MM; Widmar SB
Nurs Clin North Am; 2016 Mar; 51(1):29-43. PubMed ID: 26897422
[TBL] [Abstract][Full Text] [Related]
10. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
[TBL] [Abstract][Full Text] [Related]
11. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
[TBL] [Abstract][Full Text] [Related]
12. Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice.
Muñiz-Lozano A; Rollini F; Franchi F; Angiolillo DJ
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):197-213. PubMed ID: 23818658
[TBL] [Abstract][Full Text] [Related]
13. The Cape Chacma baboon is not suitable for evaluating human targeted anti-GPVI agents.
Janse van Rensburg WJ; Badenhorst PN; Roodt JP
Platelets; 2015; 26(6):552-7. PubMed ID: 25165849
[TBL] [Abstract][Full Text] [Related]
14. Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke.
Induruwa I; Jung SM; Warburton EA
Int J Stroke; 2016 Aug; 11(6):618-25. PubMed ID: 27312676
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the interactions between collagen and its receptors on platelets.
Deckmyn H; De Meyer SF; Broos K; Vanhoorelbeke K
Handb Exp Pharmacol; 2012; (210):311-37. PubMed ID: 22918737
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Glycoprotein VI and Its Downstream Signaling Pathways as an Antiplatelet Target.
Fuentes E
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077280
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotics in acute coronary syndromes.
Bonaca MP; Steg PG; Feldman LJ; Canales JF; Ferguson JJ; Wallentin L; Califf RM; Harrington RA; Giugliano RP
J Am Coll Cardiol; 2009 Sep; 54(11):969-84. PubMed ID: 19729112
[TBL] [Abstract][Full Text] [Related]
19. Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases.
Harbi MH; Smith CW; Nicolson PLR; Watson SP; Thomas MR
Platelets; 2021 Jan; 32(1):29-41. PubMed ID: 33307909
[TBL] [Abstract][Full Text] [Related]
20. Current state and novel approaches of antiplatelet therapy.
Metharom P; Berndt MC; Baker RI; Andrews RK
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1327-38. PubMed ID: 25838432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
